These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 4966686

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA, Fisher LM.
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract] [Full Text] [Related]

  • 8. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS, Miraglia CC, Rickles FR, Shuman MA.
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [Abstract] [Full Text] [Related]

  • 9. Delayed fibrin polymerization due to removal of calcium ions.
    Godal HC.
    Scand J Clin Lab Invest; 1969 Aug; 24(1):29-33. PubMed ID: 4986919
    [No Abstract] [Full Text] [Related]

  • 10. Human factor XIII: fibrin-stabilizing factor.
    Lorand L, Losowsky MS, Miloszewski KJ.
    Prog Hemost Thromb; 1980 Aug; 5():245-90. PubMed ID: 7422874
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of a fibrin formation abnormality in a case of multiple myeloma.
    Soria J, Soria C, Samama M, Fine JM, Bousser J.
    Scand J Haematol; 1975 Oct; 15(3):207-18. PubMed ID: 812173
    [Abstract] [Full Text] [Related]

  • 12. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN, Fukui H.
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract] [Full Text] [Related]

  • 13. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA.
    Usp Sovrem Biol; 1977 Jun; 84(3):338-52. PubMed ID: 343416
    [No Abstract] [Full Text] [Related]

  • 14. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV.
    Usp Sovrem Biol; 1974 Jun; 77(1):51-69. PubMed ID: 4282801
    [No Abstract] [Full Text] [Related]

  • 15. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC.
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract] [Full Text] [Related]

  • 16. Influence of NA2-EDTA and some compounds used for dissolution of fibrin clots on the physiochemical properties of fibrinogen and fibrin.
    Godal HC, Brosstad F, Kierulf P.
    Bibl Haematol; 1977 Jul; 44():151-5. PubMed ID: 104706
    [No Abstract] [Full Text] [Related]

  • 17. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA, Halver JE, Gladner JA.
    Biochem Biophys Res Commun; 1973 Oct 01; 54(3):849-55. PubMed ID: 4148128
    [No Abstract] [Full Text] [Related]

  • 18. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M, Seelich T, Beck EA.
    Thromb Haemost; 1976 Dec 31; 36(3):582-92. PubMed ID: 14415
    [Abstract] [Full Text] [Related]

  • 19. A study of the inhibitory effect of ethylenediaminetetra-acetic acid on the thrombin-fibrinogen reaction.
    Bithell TC.
    Biochem J; 1964 Nov 31; 93(2):431-9. PubMed ID: 4953832
    [No Abstract] [Full Text] [Related]

  • 20. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D, Douglas AS.
    Drugs; 1971 Nov 31; 1(3):228-46. PubMed ID: 4256645
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.